Category: MedtronicSyndicate content

Medtronic, Lifetech expand China pacemaker deal

July 28, 2014 by Brad Perriello

Medtronic and Lifetech Scientific expand their deal to co-produce pacemakers for the Chinese market.

Medtronic, Lifetech expand China pacemaker deal

Medtronic settles insulin pump beef for $2.8M

July 25, 2014 by Arezu Sarvestani

Medtronic agrees to pay $2.8 million to close the books on a multi-state and federal lawsuit accusing the company of illegally soliciting insulin pump patients to replace their devices.

Medtronic settles insulin pump beef for $2.8M

Federal and state regulators agreed to a $2.8 million settlement with medtech titan Medtronic (NYSE:MDT) to close the books on a years-old concern over insulin infusion pumps.

Medtronic has big dreams for China's diabetes market | MassDevice.com On Call

July 25, 2014 by Arezu Sarvestani

Minnesota medical device maker Medtronic estimates that China could soon account for 20% of the company's global diabetes revenues, according to a local report.

MassDevice.com On Call

MASSDEVICE ON CALL — Medtronic (NYSE:MDT) is looking to significantly boost its reach in China, country with "the world's biggest diabetes epidemic," according to a local report.

Report: Medtronic shareholder sues to block Covidien merger

July 24, 2014 by Brad Perriello

A Medtronic shareholder is reportedly looking to block the pending, $43 billion merger with Covidien, arguing that the deal leaves stockowners on the hook for significant tax liabilities.

Report: Medtronic shareholder sues to block Covidien merger

Intersect ENT prices IPO at low end of range

July 24, 2014 by Brad Perriello

Intersect ENT prices its initial public offering at $11 per share, the low end of its predicted range, hoping to raise $55 million when XENT shares hit the NASDAQ exchange today.

Intersect ENT prices IPO at low end of range

Intersect ENT said today that it's shares should hit the NASDAQ exchange at $11 apiece, the low end of the range, for expected proceeds of $55 million.

At that price, Intersect would command a market capitalization of roughly $267 million.

Abbott CEO chides critics of corporate inversions | Medtech Wall Street news for the week of July 21, 2014

July 24, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Allergan cuts 1,500 jobs, faces SEC complaint; A countdown to failure for Valeant's hostile $53B Allergan takeover; GE Healthcare idles for another quarter

Abbott CEO defends inversions amid corporate exodus furor

July 18, 2014 by Arezu Sarvestani

Abbott CEO defends inversions amid corporate exodus furor

Medtronic tallies 175 apps for iPhones and iPads | MassDevice.com On Call

July 24, 2014 by Arezu Sarvestani

Medtech titan Medtronic has developed 175 iOS apps for internal use by its employees, according to Apple.

MassDevice.com On Call
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp